CD274 and non-small cell lung carcinoma: Similar to NSCLC (Non-Small Cell Lung Cancer) and other solid malignancies, an exploratory analysis in the Checkmate-743 trial failed to show any predictive value of programmed cell death-ligand 1 (PD-L1) [3].